China outlicensing tops US$52 billion in first 2 months on surge in global deals
- Posted on March 4, 2026
- By South China Morning Post
- 5 Views
China outlicensing tops US$52 billion in first 2 months on surge in global deals
The latest deals are Sino Biopharmaceutical’s partnership with France’s Sanofi and Antengene’s agreement with Belgium’s UCB.
